Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

231.57
-8.6200-3.59%
Post-market: 231.570.00000.00%17:37 EDT
Volume:393.26K
Turnover:91.94M
Market Cap:6.30B
PE:-3.00
High:240.39
Open:238.68
Low:228.91
Close:240.19
Loading ...

BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

GlobeNewswire
·
25 Apr

Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for

Zacks
·
24 Apr

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

GlobeNewswire
·
23 Apr

Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile?

Insider Monkey
·
22 Apr

Should You be Optimistic on Bio-Rad Laboratories’s (BIO) Outlook?

Insider Monkey
·
21 Apr

Bio-Rad Laboratories Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
18 Apr

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

THOMSON REUTERS
·
16 Apr

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

Business Wire
·
16 Apr

Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer

Business Wire
·
16 Apr

BUZZ-Life sciences firms fall as China hikes tariff on US imports

Reuters
·
09 Apr

Bio Rad Laboratories Inc : RBC Cuts Target Price to $409 From $430

THOMSON REUTERS
·
08 Apr

KALA BIO Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Apr

Further weakness as Bio-Rad Laboratories (NYSE:BIO) drops 5.0% this week, taking three-year losses to 61%

Simply Wall St.
·
04 Apr

Bio Protocol is introducing the protocol upgrade Bio V1, which includes a new Launchpad feature. BIO holders will have priority access to early project allocations.

Blockbeats
·
02 Apr

Bioton FY Net Loss At 15.7 Mln Zlotys

T-Reuters
·
01 Apr

KALA BIO Advances Eye Disease Therapies with New Funding

TIPRANKS
·
01 Apr

Bio-Techne Opens New Customer Experience Centre in Germany

Zacks
·
31 Mar

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

Zacks
·
31 Mar

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
31 Mar

BIO-key Partners with Arrow ECS Iberia to Strengthen Access to its Identity and Access Management Solutions in Spain and Portugal

GlobeNewswire
·
31 Mar